Ribosomal protein S6 kinase
From Proteopedia
(Difference between revisions)
| Line 26: | Line 26: | ||
**[[2z7s]], [[2z7r]] - hRPS6K α−1 N-terminal kinase domain+inhibitor<br /> | **[[2z7s]], [[2z7r]] - hRPS6K α−1 N-terminal kinase domain+inhibitor<br /> | ||
**[[4nif]] - hRPS6K α−1 C-terminal kinase domain + mitogen-activated protein kinase 1<br /> | **[[4nif]] - hRPS6K α−1 C-terminal kinase domain + mitogen-activated protein kinase 1<br /> | ||
| + | **[[5csf]], [[5csi]], [[5csj]], [[5csn]] - hRPS6K α−1 residues 683-735 + S100-B<br /> | ||
**[[3ubd]] - hRPS6K α−3 N-terminal kinase domain + flavonol glycoside<br /> | **[[3ubd]] - hRPS6K α−3 N-terminal kinase domain + flavonol glycoside<br /> | ||
| + | **[[5d9k]], [[5d9l]] - hRPS6K α−3 N-terminal kinase domain + inhibitor<br /> | ||
**[[4gue]] - mRPS6K α−3 N-terminal kinase domain + flavonol glycoside<br /> | **[[4gue]] - mRPS6K α−3 N-terminal kinase domain + flavonol glycoside<br /> | ||
**[[4el9]] - mRPS6K α−3 N-terminal kinase domain + inhibitor<br /> | **[[4el9]] - mRPS6K α−3 N-terminal kinase domain + inhibitor<br /> | ||
Revision as of 17:17, 28 September 2017
| |||||||||||
3D Structures of Ribosomal protein S6 kinase
Updated on 28-September-2017
References
- ↑ Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J. 2012 Jan 1;441(1):1-21. doi: 10.1042/BJ20110892. PMID:22168436 doi:http://dx.doi.org/10.1042/BJ20110892
- ↑ Kim D, Akcakanat A, Singh G, Sharma C, Meric-Bernstam F. Regulation and localization of ribosomal protein S6 kinase 1 isoforms. Growth Factors. 2009 Feb;27(1):12-21. doi: 10.1080/08977190802556986. PMID:19085255 doi:http://dx.doi.org/10.1080/08977190802556986
- ↑ Couty S, Westwood IM, Kalusa A, Cano C, Travers J, Boxall K, Chow CL, Burns S, Schmitt J, Pickard L, Barillari C, McAndrew PC, Clarke PA, Linardopoulos S, Griffin RJ, Aherne GW, Raynaud FI, Workman P, Jones K, van Montfort RL. The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design. Oncotarget. 2013 Aug 25. PMID:24072592
- ↑ Ikuta M, Kornienko M, Byrne N, Reid JC, Mizuarai S, Kotani H, Munshi SK. Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors. Protein Sci. 2007 Dec;16(12):2626-35. Epub 2007 Oct 26. PMID:17965187 doi:http://dx.doi.org/10.1110/ps.073123707
